Related references
Note: Only part of the references are listed.Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials
Bernard Levy et al.
AMERICAN JOURNAL OF HYPERTENSION (2022)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations
Paul K. Whelton et al.
CIRCULATION (2022)
Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Kamal Awad et al.
MAYO CLINIC PROCEEDINGS (2022)
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control A Secondary Analysis of a Randomized Clinical Trial
Byron C. Jaeger et al.
JAMA CARDIOLOGY (2022)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction A Report of the American College of Cardiology Solution Set Oversight Committee
Thomas M. Maddox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension A Systematic Review and Meta-Analysis
Gianfranco Parati et al.
HYPERTENSION (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Bin Zhou et al.
LANCET (2021)
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou et al.
NATURE REVIEWS CARDIOLOGY (2021)
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Weili Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
May Measurement Month 2019: results of blood pressure screening from 47 countries
Neil R. Poulter et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2021)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
Doreen M. Rabi et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications A Systematic Review and Network Meta-analysis
Jingkai Wei et al.
JAMA NETWORK OPEN (2020)
Three Public Health Interventions Could Save 94 Million Lives in 25 Years Global Impact Assessment Analysis
Vasilis Kontis et al.
CIRCULATION (2019)
A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril
Arnaud Ancion et al.
CARDIOLOGY AND THERAPY (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus A PRISMA-compliant systematic review and meta-analysis
Xiaodan Lv et al.
MEDICINE (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Guidelines on the management of arterial hypertension and related comorbidities in Latin America
Eduardo Barbos et al.
JOURNAL OF HYPERTENSION (2017)
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials
Chenhui Tai et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
Csaba Andras Dezsi et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2016)
Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
Clive Rosendorff et al.
HYPERTENSION (2015)
Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis
Jasper J. Brugts et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress
Srinivas Sriramula et al.
PLOS ONE (2015)
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial
John Chalmers et al.
HYPERTENSION (2014)
A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
Gianluigi Savarese et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of reninangiotensinaldosterone system inhibitors involving 158 998 patients
Laura C. van Vark et al.
EUROPEAN HEART JOURNAL (2012)
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
E. Imai et al.
DIABETOLOGIA (2011)
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor
Hui Yang et al.
PEPTIDES (2011)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
William L. Baker et al.
ANNALS OF INTERNAL MEDICINE (2009)
ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload
Patrick Mueller et al.
CARDIOVASCULAR RESEARCH (2009)
Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Effects of ARB or ACE-Inhibitor Administration on Plasma Levels of Aldosterone and Adiponectin in Hypertension
Tetsuya Nakamura et al.
INTERNATIONAL HEART JOURNAL (2009)
Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland
Enrique Sanchez-Lemus et al.
ENDOCRINOLOGY (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Treatment of hypertension in patients 80 years of age or older
Nigel S. Beckett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telmisartan to prevent recurrent stroke and cardiovascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004
Nathan D. Wong et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT
Claudio Ceconi et al.
CARDIOVASCULAR RESEARCH (2007)
Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
P. Dandona et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2:: implications for atherosclerotic plaque rupture
MP Kim et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy
CA Daly et al.
EUROPEAN HEART JOURNAL (2005)
Angiotensin IV activates the nuclear transcription factor-κB and related proinflammatory genes in vascular smooth muscle cells
V Esteban et al.
CIRCULATION RESEARCH (2005)
Mechanisms for the clinical benefits of angiotensin II receptor blockers
RE Schmieder
AMERICAN JOURNAL OF HYPERTENSION (2005)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
CB Granger et al.
LANCET (2003)
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality
JP Collet et al.
CIRCULATION (2003)
The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial
H Lithell et al.
JOURNAL OF HYPERTENSION (2003)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
K Dickstein et al.
LANCET (2002)
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist
T Ito et al.
STROKE (2002)
Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells
JL Mehta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Angiotensin receptor Blockers in heart failure: Meta-analysis of randomized controlled trials
P Jong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury
L Wu et al.
CIRCULATION (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)
LANCET (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S MacMahon et al.
LANCET (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The QUinapril Ischemic Event Trial (OUIET): Evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function
B Pitt et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Localization and function of angiotensin AT(1) receptors
AM Allen et al.
AMERICAN JOURNAL OF HYPERTENSION (2000)
Share Paper
